-
Disclosure of share transfer from Inven2 AS
-
Disclosure of Shareholding – Gjelsten Holding AS
-
ZLNA – New registered share capital
-
ZLNA – Issuance of shares through set-off of option exercise fee
-
Zelluna ASA Reports First Quarter 2025 Financial Results and Provides General Business Update
-
Zelluna ASA: Invitation to First Quarter 2025 results webcast presentation
-
Zelluna ASA – Annual General Meeting held on April 29, 2025
-
Zelluna Reaches Major Milestone with Manufacturing Process Established in Preparation for Clinical Entry of ZI-MA4-1, its Novel TCR-NK Therapy Targeting Solid Tumours
-
Zelluna ASA [ZLNA]: Notification of transaction by close associate of primary insider
-
Zelluna ASA [ZLNA]: Notice of Annual General Meeting on April 29, 2025
